Sima P. Porten MD, MPH

Sima P Porten, MD, MPH

Sima P. Porten MD, MPH

Associate Professor in Residence


BA, 2001 Northwestern University, College of Arts and Sciences, Classics
MD, 2006, Northwestern University, Feinberg School of Medicine, Medicine
MPH, 2006, Northwestern University, Feinberg School of Medicine, Public Health
Resident, 2008, University of California, San Francisco, Surgery
Resident, 2012, University of California, San Francisco, Urology
Fellow, 2014, University of Texas, MD Anderson Cancer Center, Urology Oncology


Sima Porten received her undergraduate, doctoral and public health degrees from Northwestern University completing her education in June 2006. She was inducted into the Alpha Omega Alpha Honor Society during medical school and also completed a Howard Hughes Medical Institute-NIH Research Scholars fellowship during that time. She then completed her urology residency training at University of California, San Francisco where she received the Julius R. Krevans Award for Clinical Excellence.  She then completed her Urologic Oncology Fellowship at The University of Texas, MD Anderson Cancer Center. During fellowship, she was awarded the John Quale Travel Fellowship for her research in Bladder Cancer. Currently, she is part of the multidisciplinary urologic oncology team of the UCSF Helen Diller Family Comprehensive Cancer Center where she continues to pursue her clinical and research interests in bladder cancer, upper tract urothelial cancer, and high-risk prostate cancer. In the start of the academic year in 2020, Dr. Porten earned her associate professorship position in urology.

Clinical Interests

Dr. Porten’s clinical interests include the diagnosis and treatment of genitourinary malignancy, including minimally invasive approaches to cancer treatment. She is an active member of the American Urological Association (AUA), American Society of Clinical Oncology, Society of Women in Urology, and the Society of Urologic Oncology.

Research Interests

Dr. Porten’s research interests focus mainly in the diagnosis and management of urothelial carcinoma (bladder and upper tract). In studying the biologic basis of urothelial carcinoma using genomic techniques, Dr. Porten hopes to develop new tests and novel therapeutics to bring personalized medicine to patients with bladder cancer.

Patient Contact

Note that UCSF Urology utilizes an online system for scheduling appointments called MyChart. This is our preferred method of communications. If you are not yet signed up for MyChart, call 415.514.6000 to get an activation code and help signing up.
For new patients click here and follow instructions under "Urologic Surgical Oncology" 

For existing patients, general questions and making follow up appointment:

415.353.7011  (Phone)
415.353.9875  (Fax)

1825 4th Street
6th floor Baker Precision Cancer Medicine Building
San Francisco, CA 94158

Practice Manager
415.514.8825  (Phone)
415.353.7093  (Fax)


Academic Contact

415.885.3695  (Phone)
415.476.5366  (Fax)

University of California, San Francisco
Department of Urology, Mailcode 1695
550 16th Street, 6th Floor
San Francisco, CA 94143